Can a duodenal ulcer become malignant? | Duodenal ulcer

Can a duodenal ulcer become malignant? A malignant (malignant) degeneration rarely occurs in duodenal ulcers. Malignant degeneration occurs in about 1-2% of patients with peptic ulcer, and in duodenal ulcer degeneration is much rarer. In chronic cases, degeneration is generally more probable, which is why an endoscopic examination should be performed at least every two … Can a duodenal ulcer become malignant? | Duodenal ulcer

Diagnosis | Duodenal ulcer

Diagnosis The diagnosis of duodenal ulcer consists of several steps. First of all, a detailed patient interview (anamnesis) is made with subsequent examination of the patient. A rectal examination by palpation is seldom carried out during which non-visible – so-called occult – blood in the stool can be detected. A reliable diagnosis is made by … Diagnosis | Duodenal ulcer

Ranitidine

Ranitidine is an active ingredient which belongs to the class of histamine H2-receptor blockers. Ranitidine is mainly found in drugs prescribed for the treatment of diseases where the amount of stomach acid is the cause of the disease. There are different concentrations of ranitidine in drugs that are believed to inhibit acid production in the … Ranitidine

Proton pump inhibitors in comparison

Proton pump inhibitors contain active ingredients that reduce the acid content in the stomach by blocking the so-called proton pump (H+/K+-ATPase). Proton pump inhibitors are certified in Germany for illnesses such as reflux disease, gastritis, ulcers in the stomach and duodenum, and a pathologically increased production of gastric acid. Frequent application finds proton pump inhibitors … Proton pump inhibitors in comparison

Review | Proton pump inhibitors in comparison

Review Immediately after the introduction of the drug esomeprazole, it was heavily criticized. The manufacturer stated that due to the dosage form (Nexium Mups®) and the slower metabolism (processing of the active ingredient in the liver) of the active ingredient esomeprazole, there was a considerable advantage over conventional, older drugs. This assertion should be backed … Review | Proton pump inhibitors in comparison

Duodenum

Position and course The duodenum is a part of the small intestine and is the link between the stomach and the jejunum. It has a length of approximately 30 cm and is anatomically divided into 4 different sections depending on its course. After leaving the pylorus, the chyme reaches the upper part of the duodenum … Duodenum

Microscopic structure | Duodenum

Microscopic structure The different layers of the duodenum in cross-section correspond to those of the rest of the digestive tract. From the outside, the duodenum is surrounded by connective tissue (tunica adventitia), which contains both blood and lymph vessels. This is bordered by a muscle layer, the so-called tunica muscularis. It contains an outer longitudinal … Microscopic structure | Duodenum

Nexium®

Proton pump inhibitor, proton pump inhibitor, “stomach protection” Daily a total of 2-3 liters of gastric juice are produced by different cells in the stomach. It contains aggressive substances such as hydrochloric acid and digestive enzymes, but also protective substances that prevent the stomach from digesting itself. The pH value, which indicates how acidic a … Nexium®

Trade name | Nexium®

Trade name Nexium® Chemical name Esomeprazole Dosage forms Nexium® Mups 20mg (Multiple Unit Pellet System) Nexium® Mups 40mg (Multiple Unit Pellet System) Nexium® 40mg powder for the preparation of an infusion solution Mode of action Nexium® with its active ingredient esomeprazole belongs to the group of proton pump inhibitors. The active ingredient is absorbed as … Trade name | Nexium®